Top Markets
Coin of the day
Evogene Ltd. Evogene Ltd.

Evogene Ltd.

EVGN
Rang in Aktien #41005
Evogene Ltd. is a computational biology firm specializing in the identification... Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.
Aktienkurs
$0.62045126
Marktkapitalisierung
$53.46K
Veränderung (1 Tag)
3.18%
Veränderung (1 Jahr)
-50.95%
Land
IL
Handel Evogene Ltd. (EVGN)

Kategorie

Preis EVGN mit Marktkapitalisierung von B
Evogene Ltd. Evogene Ltd.
EVGN
$0.62045126
Marktkapitalisierung von Evogene Ltd.(EVGN)
Marktkapitalisierung: $53.46K
Mit Stand August 2026 hat Evogene Ltd. eine Marktkapitalisierung von $53.46K. Das macht Evogene Ltd. laut unseren Daten zum 41005th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Evogene Ltd. von 2007 bis 2026
EVGN im Vergleich zu den Top 5 der beliebtesten stocks
Preis für EVGN Vermögenswert B Marktkapitalisierung von B Ergebnisse
Evogene Ltd. Evogene Ltd.
$63,222,269 $53.46K
$5.448T +10,189,723,520.24%
Evogene Ltd. Evogene Ltd.
$51,719,715 $53.46K
$4.457T +8,335,822,311.85%
Evogene Ltd. Evogene Ltd.
$48,219,396 $53.46K
$4.155T +7,771,665,308.85%
Evogene Ltd. Evogene Ltd.
$42,898,907 $53.46K
$3.697T +6,914,146,061.88%
Evogene Ltd. Evogene Ltd.
$33,502,958 $53.46K
$2.887T +5,399,772,702.57%